AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
More than 50 years after its debut, Israel's Kfir fighter jet gets a new lease on life
2
Echo: “Employees have become very good at identifying performative culture”
3
How Israel’s AI surveillance breakthrough in Iran is reshaping global intelligence
4
Former Microsoft and Tesla security leaders emerge with $35 million for Pi
5
Head of Google Research: “AI will enhance human innovation, but the role of humans is greater than ever”
More news

Emalex Biosciences

2 stories about Emalex Biosciences
בניין חברת טבע כפר סבא

The deal that signals Teva is back

30.04.26|Sophie Shulman
A calculated biotech acquisition and strong earnings revive confidence in the pharma giant.
המרכז הלוגיסטי של חברת טבע בשוהם

Teva to acquire Emalex in deal worth up to $900 million

29.04.26|Sophie Shulman, CTech
The move strengthens Teva's pipeline with Tourette’s treatment and supports its “Beyond Growth” strategy.